Consequently, we not only defined a number of new BCC susceptibility loci but more significantly identified three dominant processes underlying that susceptibility—cell death (25/46 SMR genes), cell cycle (23/46 SMR genes), and immune regulation (20/46 SMR genes). The gene discussed is LYPD4; the disease is skin basal cell carcinoma.